Diagnostic value of combined ¹⁸F-FDG PET/MRI for staging and restaging in paediatric oncology. (Q53144858)

11 May 2018

title

Diagnostic value of combined ¹⁸F-FDG PET/MRI for staging and restaging in paediatric oncology. (English)

1 reference

11 May 2018

Fluorodeoxyglucose Positron Emission Tomography

main subject

1 reference

5

Peter Bartenstein

1 reference

11 May 2018

author name string

Thomas Pfluger

1

1 reference

11 May 2018

Henriette I Melzer

2

1 reference

11 May 2018

Wolfgang P Mueller

3

1 reference

11 May 2018

Eva Coppenrath

4

1 reference

11 May 2018

Michael H Albert

6

1 reference

11 May 2018

Irene Schmid

7

1 reference

11 May 2018

publication date

28 August 2012

1 reference

11 May 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

11 May 2018

volume

39

1 reference

11 May 2018

issue

11

1 reference

11 May 2018

page(s)

1745-1755

1 reference

11 May 2018

Outcomes for children and adolescents with cancer: challenges for the twenty-first century

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Recommendations on the use of 18F-FDG PET in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

An outlook on future design of hybrid PET/MRI systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Diagnostic value of PET/CT for the staging and restaging of pediatric tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

18F-FDG PET/CT in paediatric lymphoma: comparison with conventional imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Multimodality imaging: an update on PET/CT technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Cancer risks following diagnostic and therapeutic radiation exposure in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

PET/MRI: paving the way for the next generation of clinical multimodality imaging applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Whole-body MRI in children: current status and future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

A look ahead: PET/MR versus PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Simultaneous PET-MRI: a new approach for functional and morphological imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

The impact of PET scanning on management of paediatric oncology patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Ganglioneuroma : primary tumor or maturation of a suspected neuroblastoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Clinical applications of positron emission tomography-computed tomography in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

[(18)F]FDG in childhood lymphoma: clinical utility and impact on management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Magnetic resonance imaging of abdominal masses in the pediatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

MRI of the marrow in the paediatric skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Impact of FDG-PET/CT in the management of lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

PET/CT in paediatric oncology: indications and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

18F-FDG PET in children with lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

PET-MRI fusion in head-and-neck oncology: current status and implications for hybrid PET/MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2228-3

Whole-body hybrid PET/MRI: ready for clinical use?

21 January 2018

1 reference

12 December 2020

The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions.

1 reference

12 December 2020

Glycogenolysis versus glucose transport in human granulocytes: differential activation in phagocytosis and chemotaxis

1 reference

12 December 2020

Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.

1 reference

12 December 2020

FDG PET imaging of childhood sarcomas

1 reference

12 December 2020

Report of the Committee on Hodgkin's Disease Staging Classification

1 reference

12 December 2020

A combined PET/CT scanner for clinical oncology.

1 reference

12 December 2020

10.1007/S00259-012-2228-3

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018